Zelira Therapeutics Limited

Zelira Therapeutics Limitedverified

ZLD.AX

Price:

$0.63

Market Cap:

$7.15M

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and di...[Read more]

Industry

Biotechnology

IPO Date

2003-07-25

Stock Exchange

ASX

Ticker

ZLD.AX

The Enterprise Value as of January 2025 (TTM) for Zelira Therapeutics Limited (ZLD.AX) is 12.51M

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 12.51M. This represents a change of 5.11% compared to the average of 11.90M of the last 4 quarters.

Zelira Therapeutics Limited (ZLD.AX) Historical Enterprise Value (quarterly & annually)

How has ZLD.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Zelira Therapeutics Limited over the last ten years is 24.50M. The current 12.51M Enterprise Value has changed 5.01% with respect to the historical average. Over the past ten years (40 quarters), ZLD.AX's Enterprise Value was at its highest in in the December 2020 quarter at 92.10M. The Enterprise Value was at its lowest in in the June 2012 quarter at -156944.92.

Quarterly (TTM)
Annual

Average

24.50M

Median

22.07M

Minimum

1.12M

Maximum

62.27M

Zelira Therapeutics Limited (ZLD.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 663.01%

Maximum Annual Enterprise Value = 62.27M

Minimum Annual Increase = -87.79%

Minimum Annual Enterprise Value = 1.12M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20249.11M-41.22%
202315.49M178.90%
20225.56M-87.79%
202145.50M1.67%
202044.75M56.24%
201928.64M-54.01%
201862.27M116.31%
201728.79M663.01%
20163.77M236.14%
20151.12M205.70%

Zelira Therapeutics Limited (ZLD.AX) Average Enterprise Value

How has ZLD.AX Enterprise Value performed in the past?

The current Enterprise Value of Zelira Therapeutics Limited (ZLD.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.05M

5-year avg

24.08M

10-year avg

24.50M

Zelira Therapeutics Limited (ZLD.AX) Enterprise Value vs. Peers

How is ZLD.AX’s Enterprise Value compared to its peers?

Zelira Therapeutics Limited’s Enterprise Value is less than Creso Pharma Limited (28.39M), less than MGC Pharmaceuticals Limited (21.58M), less than Botanix Pharmaceuticals Limited (756.80M), less than Cann Group Limited (91.19M), less than Althea Group Holdings Limited (19.99M),

Build a custom stock screener for Zelira Therapeutics Limited (ZLD.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLD.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Zelira Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Zelira Therapeutics Limited (ZLD.AX)?

What is the 3-year average Enterprise Value for Zelira Therapeutics Limited (ZLD.AX)?

What is the 5-year average Enterprise Value for Zelira Therapeutics Limited (ZLD.AX)?

How does the current Enterprise Value for Zelira Therapeutics Limited (ZLD.AX) compare to its historical average?